RecruitingNot ApplicableNCT06618638

Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment

Clinical Trial for Shared Decision Making Model for Choosing Pharmacotherapy in ADPKD Patients

Sponsor

Seoul National University Hospital

Enrollment

340 participants

Start Date

Oct 21, 2024

Study Type

INTERVENTIONAL

Conditions

ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Summary

The purpose of this study is to generate clinical evidence and assess the feasibility of a shared decision-making (SDM) model for the selection of Tolvaptan in patients with ADPKD.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Shared decision making model and a behavioral approach called Usual Care for people with adpkd (autosomal dominant polycystic kidney disease). The study is currently recruiting participants at 9 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALShared decision making model

Shared decision making model for choosing pharmacotherapy in ADPKD patients. This newly developed shared decision making model follows the SHARE approach and includes patient education, identifying values and preferences, reaching a decision and evaluating.

BEHAVIORALUsual Care

Usual care for ADPKD patients

Locations(9)

Hallym University Kangnam Sacred Heart Hospital

Anyang-si, Gyeonggi-do, South Korea

Seoul National University Hospital

Seoul, Republic of Korea, South Korea

InjeUniversityBusanPaikHospital

Busan, South Korea

Keimyung University Dongsan Medical Center

Daegu, South Korea

Chonnam National University Hospital

Gwangju, South Korea

Kangbuk Samsung Hospital

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Seoul National University Boramae Hospital

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06618638

Related Trials

The German ADPKD Tolvaptan Treatment Registry

NCT0249752112 locations

Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT068006511 location